NeuroMetrix, Inc. financial data

Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2024 - 31 Mar 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1245% % -27%
Quick Ratio 101% % -21%
Debt-to-equity 8.7% % 27%
Return On Equity -47% % -50%
Return On Assets -43% % -48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,059,693 shares 3.7%
Common Stock, Shares, Outstanding 2,051,028 shares 34%
Entity Public Float $6,900,000 USD -16%
Common Stock, Value, Issued $205 USD 35%
Weighted Average Number of Shares Outstanding, Basic 1,969,858 shares 89%
Weighted Average Number of Shares Outstanding, Diluted 1,969,858 shares 89%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue $1,353,170 USD -31%
Research and Development Expense $1,792,610 USD -35%
Selling and Marketing Expense $2,337,644 USD -31%
General and Administrative Expense $6,331,450 USD 28%
Operating Income (Loss) $8,782,037 USD -23%
Nonoperating Income (Expense) $975,982 USD 57%
Net Income (Loss) Attributable to Parent $7,806,055 USD -20%
Earnings Per Share, Basic -4 USD/shares 37%
Earnings Per Share, Diluted -4 USD/shares 37%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,427,784 USD -18%
Cash, Cash Equivalents, and Short-term Investments $13,100,000 USD -27%
Accounts Receivable, after Allowance for Credit Loss, Current $192,916 USD -63%
Inventory, Net $1,347,507 USD -14%
Assets, Current $15,013,511 USD -28%
Property, Plant and Equipment, Net $199,419 USD -32%
Operating Lease, Right-of-Use Asset $111,197 USD -56%
Other Assets, Noncurrent $26,400 USD 0%
Assets $15,324,127 USD -28%
Accounts Payable, Current $363,304 USD 69%
Accrued Liabilities, Current $541,820 USD -38%
Liabilities, Current $1,012,476 USD -18%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $1,012,476 USD -24%
Accumulated Other Comprehensive Income (Loss), Net of Tax $60,949 USD -75%
Retained Earnings (Accumulated Deficit) $217,915,408 USD -3.7%
Stockholders' Equity Attributable to Parent $14,311,651 USD -29%
Liabilities and Equity $15,324,127 USD -28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,081,401 USD -86%
Net Cash Provided by (Used in) Financing Activities $1,471,099 USD
Net Cash Provided by (Used in) Investing Activities $138,286 USD
Common Stock, Shares Authorized 25,000,000 shares 0%
Common Stock, Shares, Issued 2,051,028 shares 34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $472,016 USD 76%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,427,784 USD -18%
Deferred Tax Assets, Valuation Allowance $8,868,155 USD 38%
Deferred Tax Assets, Gross $8,896,179 USD 37%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,985,277 USD -27%
Lessee, Operating Lease, Liability, to be Paid $117,431 USD -59%
Property, Plant and Equipment, Gross $1,030,172 USD 0%
Operating Lease, Liability, Current $107,352 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year One $117,431 USD -29%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $6,094,424 USD 42%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $232,165,904 USD 0.96%
Depreciation, Depletion and Amortization $24,908 USD 144%